F-star Therapeutics FSTX

$ 7.12 0.0%

Quarterly report 2022-Q3
added 11-10-2022

F-star Therapeutics Balance Sheet 2011-2024 | FSTX

Annual Balance Sheet F-star Therapeutics

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-68 M	-15.4 M	10.7 M	-	-	-	-	-	-	-	-
Long Term Debt	9.6 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	906 K	539 K	355 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	3.64 M	52 K	-	-	-	-	-	-	-	-
Total Current Liabilities	12.1 M	17 M	5.41 M	4.25 M	4.43 M	3.5 M	-	-	-	-	-
Total Liabilities	26.2 M	20.6 M	29.9 M	-	-	-	-	-	-	-	-
Deferred Revenue	-	300 K	442 K	-	-	-	-	-	-	-	-
Retained Earnings	-78.5 M	-47.2 M	-21.5 M	-	-	-	-	-	-	-	-
Total Assets	123 M	63.6 M	38.5 M	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	78.5 M	18.5 M	28.7 M	14.7 M	23.6 M	10.7 M	4.35 M	-	-	-	-
Book Value	96.9 M	43 M	8.54 M	-	-	-	-	-	-	-	-
Total Shareholders Equity	96.9 M	43 M	8.54 M	55.9 M	34.7 M	17 M	11 M	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet F-star Therapeutics

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	8.52 M	9.4 M	9.68 M	9.6 M	9.54 M	9.47 M	3.38 M	-	-	-	2.62 M	19.1 M	19 M	19.1 M	19.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	26.8 M	29 M	26.5 M	26.2 M	24.7 M	26 M	18.6 M	20.6 M	20.6 M	20.6 M	20.6 M	29.9 M	27.7 M	27.7 M	27.7 M	13 M	13 M	13 M	13 M	17.6 M	17.6 M	17.6 M	17.6 M	9.86 M	9.86 M	9.86 M	9.86 M	3.55 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	300 K	300 K	300 K	300 K	442 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-128 M	-110 M	-90.5 M	-78.5 M	-83.2 M	-72.7 M	-57 M	-47.2 M	-47.2 M	-47.2 M	-47.2 M	-21.5 M	-126 M	-126 M	-126 M	-102 M	-102 M	-102 M	-102 M	-79.2 M	-79.2 M	-79.2 M	-79.2 M	-51.5 M	-51.5 M	-51.5 M	-51.5 M	-34.2 M	-34.2 M	-34.2 M	-34.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	83.7 M	101 M	115 M	123 M	115 M	125 M	53.4 M	63.6 M	63.6 M	63.6 M	63.6 M	38.5 M	63.2 M	63.2 M	63.2 M	68.8 M	68.8 M	68.8 M	68.8 M	52.3 M	52.3 M	52.3 M	52.3 M	26.9 M	26.9 M	26.9 M	26.9 M	14.6 M	14.6 M	14.6 M	14.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	35.6 M	53 M	68.8 M	78.5 M	71 M	81.6 M	3.68 M	18.5 M	18.5 M	18.5 M	18.5 M	4.9 M	28.7 M	28.7 M	28.7 M	14.7 M	14.7 M	14.7 M	14.7 M	23.6 M	23.6 M	23.6 M	23.6 M	10.7 M	10.7 M	10.7 M	10.7 M	4.35 M	4.35 M	4.35 M	4.35 M	1.57 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	56.9 M	71.6 M	88.2 M	96.9 M	90.1 M	99 M	34.8 M	43 M	43 M	43 M	43 M	8.54 M	35.5 M	35.5 M	35.5 M	55.9 M	55.9 M	55.9 M	55.9 M	34.7 M	34.7 M	34.7 M	34.7 M	17 M	17 M	17 M	17 M	11 M	14.6 M	14.6 M	14.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	56.9 M	71.6 M	88.2 M	96.9 M	90.1 M	99.2 M	35 M	43 M	43 M	43 M	43 M	8.54 M	35.5 M	35.5 M	35.5 M	1.08 M	55.9 M	55.9 M	55.9 M	34.7 M	34.7 M	34.7 M	34.7 M	17 M	17 M	17 M	17 M	11 M	11 M	11 M	11 M	12.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency